DNA sequencing assay to identify constituents of the microbiome of species from complex samples
Shoreline Biome has created discovery tools that are advancing the leading edge of understanding how the human microbiome functions across the entire landscape of human health and disease. The initial products from Shoreline Biome, developed in collaboration with George Weinstock at the Jackson Lab for Genomic Medicine, are the first DNA sequencing assays to comprehensively, rapidly, and inexpensively identify all members of the microbiome down to the subspecies or strain level. These results are achieved through our superior cell breaking technology and rational product design. Our companion analysis software enables straightforward identification and quantitation of all of the bacteria in microbiome samples.
Thomas Jarvie, Co-Founder & CEO
Mark Driscoll, Co-Founder & CTO